IL91251A - A process for the preparation of a substance with pharmacological activity that has an anti-cancer effect and a substance derived from this process - Google Patents

A process for the preparation of a substance with pharmacological activity that has an anti-cancer effect and a substance derived from this process

Info

Publication number
IL91251A
IL91251A IL9125189A IL9125189A IL91251A IL 91251 A IL91251 A IL 91251A IL 9125189 A IL9125189 A IL 9125189A IL 9125189 A IL9125189 A IL 9125189A IL 91251 A IL91251 A IL 91251A
Authority
IL
Israel
Prior art keywords
ascites
cohn
cancer
cells
process according
Prior art date
Application number
IL9125189A
Other languages
English (en)
Hebrew (he)
Other versions
IL91251A0 (en
Original Assignee
Bio Defence Inst Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Defence Inst Co Ltd filed Critical Bio Defence Inst Co Ltd
Publication of IL91251A0 publication Critical patent/IL91251A0/xx
Publication of IL91251A publication Critical patent/IL91251A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Peptides Or Proteins (AREA)
IL9125189A 1988-08-10 1989-08-08 A process for the preparation of a substance with pharmacological activity that has an anti-cancer effect and a substance derived from this process IL91251A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63199688A JPH0688906B2 (ja) 1988-08-10 1988-08-10 制癌作用を有する生物活性物質の製造方法およびそれにより得られる制癌作用を有する生物活性物質

Publications (2)

Publication Number Publication Date
IL91251A0 IL91251A0 (en) 1990-03-19
IL91251A true IL91251A (en) 1994-12-29

Family

ID=16411959

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9125189A IL91251A (en) 1988-08-10 1989-08-08 A process for the preparation of a substance with pharmacological activity that has an anti-cancer effect and a substance derived from this process

Country Status (15)

Country Link
EP (1) EP0354492B1 (fr)
JP (1) JPH0688906B2 (fr)
KR (1) KR940003053B1 (fr)
AT (1) ATE110733T1 (fr)
AU (1) AU616548B2 (fr)
CA (1) CA1326996C (fr)
DE (1) DE68917830T2 (fr)
DK (1) DK386689A (fr)
ES (1) ES2059656T3 (fr)
FI (1) FI100457B (fr)
HK (1) HK1005190A1 (fr)
HU (1) HU205257B (fr)
IL (1) IL91251A (fr)
NO (1) NO179327C (fr)
NZ (1) NZ230250A (fr)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261976A (en) * 1978-10-03 1981-04-14 The Massachusetts General Hospital Method and glycoprotein composition for inhibition of growth of transformed cells and tumors
JPS57140725A (en) * 1981-12-28 1982-08-31 Dainippon Pharmaceut Co Ltd Physiologically active substance having carcinostatic action
JPS58141785A (ja) * 1982-02-16 1983-08-23 Nippon Shinyaku Co Ltd 抗腫瘍物質の製法
JPS5982315A (ja) * 1982-11-02 1984-05-12 Yamanouchi Pharmaceut Co Ltd 腫瘍壊死因子の製造法
JPS6067429A (ja) * 1983-09-22 1985-04-17 Sendai Biseibutsu Kenkyusho 生理活性物質の製造法
JPS6248631A (ja) * 1985-08-26 1987-03-03 Dai Ichi Seiyaku Co Ltd 抗腫瘍血清因子
JPS6256430A (ja) * 1985-09-04 1987-03-12 Takeda Chem Ind Ltd 抗腫瘍性酸性糖蛋白

Also Published As

Publication number Publication date
DK386689A (da) 1990-02-11
HUT53808A (en) 1990-12-28
ES2059656T3 (es) 1994-11-16
KR940003053B1 (ko) 1994-04-13
FI893765A0 (fi) 1989-08-09
IL91251A0 (en) 1990-03-19
HU205257B (en) 1992-04-28
FI893765A (fi) 1990-02-11
EP0354492B1 (fr) 1994-08-31
AU616548B2 (en) 1991-10-31
CA1326996C (fr) 1994-02-15
NO179327B (no) 1996-06-10
KR900002790A (ko) 1990-03-23
AU3936589A (en) 1990-02-15
EP0354492A3 (en) 1990-08-01
HK1005190A1 (en) 1998-12-24
DK386689D0 (da) 1989-08-07
ATE110733T1 (de) 1994-09-15
JPH0688906B2 (ja) 1994-11-09
FI100457B (fi) 1997-12-15
NO893194D0 (no) 1989-08-08
JPH0248532A (ja) 1990-02-19
NO179327C (no) 1996-09-18
NO893194L (no) 1990-02-12
EP0354492A2 (fr) 1990-02-14
DE68917830D1 (de) 1994-10-06
DE68917830T2 (de) 1994-12-22
NZ230250A (en) 1992-09-25

Similar Documents

Publication Publication Date Title
Storb et al. Treatment of established human graft-versus-host disease by antithymocyte globulin
US4843067A (en) Polysaccharide containing pharmaceutical composition for increasing the immune function
CN105664152B (zh) 一种具有免疫调节作用的双链聚核苷酸—ε-聚赖氨酸复合物及其制备使用方法
CA2049548C (fr) Bacterie produisant de la lipopolysaccharide, lipopolysaccharides, et medicaments contenant de la lipopolysaccharide et medicaments a usage veterinaire
CN106177187B (zh) 具有增效减毒抗肝癌作用的茶多酚茶多糖组合物
Sadler et al. Radiolabelling of Corynebacterium parvum and its distribution in mice
EP0354492B1 (fr) Procédé de préparation d'une substance physiologiquement active ayant une activité anticancéreuse et substance ainsi obtenue
KR101609179B1 (ko) 다발성 경화증의 예방 및 치료 효과가 강화된 말똥진흙버섯의 추출 분획물의 제조방법
Alexander et al. Stimulants of cellular proliferation in wounds
CN110357881B (zh) 苦木中β-卡波林型生物碱的提取工艺和应用
EP0086475A2 (fr) Méthode de préparation de substances anti-tumorales
US20020115190A1 (en) Culture of staphylococcus aureus and a method for preparing the same
US4479935A (en) Fractions extracted from aerobic bacteria, endowed with antitumoral, antibacterial and interferon inducing properties, and process for their preparation
Aptekman et al. Evidence of resistance to tumor graft in early stages of induced oncolysis
US20060034933A1 (en) Freeze-dried lecithin nanometer powder injection of ursolic acid and its preparation method
US20060127518A1 (en) Red nocardia cell wall skeleton preparation process and its therapeutic use on treating cervical erosion
CN112251402B (zh) 蛋白肽、冻干粉、口服液及其制备方法
CN102441160A (zh) 一种胸腺肽α1药物组合物及其制备方法
SU1304736A3 (ru) Способ получени противоопухолевого средства
CN1332847A (zh) 含有香菇菌丝体提取物的lak活性筛选材料以及使用该提取物的lak活性筛选方法
CA1243955A (fr) Potentiateur conferant de la resistance a l'infection
CN113440574A (zh) 一种中药组合物在制备治疗病毒性心肌炎药物中的应用
KR0183443B1 (ko) 연쇄상 구균으로부터 항종양 및 면역증가 활성성분의 제조방법
EP0230556B1 (fr) Fraction obtenue à partir de Listeria monocytogenes possédant une activité thérapeutique, procédé pour sa préparation et composition pharmaceutique la contenant
CN115364206A (zh) 一种联合抗肿瘤疫苗及其制备方法

Legal Events

Date Code Title Description
KB Patent renewed
RH1 Patent not in force